Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B when added to existing preventatives
NIH-funded study observes no significant reduction of infection rates at age 6 months.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Children | Hepatitis | Hepatitis B | National Institutes of Health (NIH) | Study